Rapid Micro Biosystems Inc (RPID) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

By Yahoo! Finance | Nov 2, 2024 at 03:03 AM EST

In Q4, focus remains on prudent guidance due to market challenges, but potential upside exists if Q4 execution surpasses expectations. Priority on high ROI projects and funding boosts confidence for 2025. Strong uptake in biologics and cell and gene therapies with sterility reinforcing growth.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.